Biogen (BIIB) Valuation Declined While Westend Advisors Lowered Its Holding by $6.67 Billion; Phillips 66 (PSX) Stake Held by Northcoast Asset Management Llc

Biogen Inc. (NASDAQ:BIIB) Logo

Northcoast Asset Management Llc increased its stake in Phillips 66 (PSX) by 23.26% based on its latest 2018Q3 regulatory filing with the SEC. Northcoast Asset Management Llc bought 2,792 shares as the company’s stock declined 22.04% with the market. The institutional investor held 14,796 shares of the integrated oil company at the end of 2018Q3, valued at $1.67M, up from 12,004 at the end of the previous reported quarter. Northcoast Asset Management Llc who had been investing in Phillips 66 for a number of months, seems to be bullish on the $42.73 billion market cap company. The stock increased 0.73% or $0.67 during the last trading session, reaching $92.66. About 1.35M shares traded. Phillips 66 (NYSE:PSX) has declined 9.22% since January 10, 2018 and is downtrending. It has underperformed by 9.22% the S&P500. Some Historical PSX News: 27/04/2018 – Phillips 66 1Q EPS $1.07; 24/04/2018 – PHILLIPS 66: PIPELINE TO BE PLACED IN SERVICE BY END OF 2019; 02/05/2018 – Phillips 66 Well Positioned for IMO 2020 Rule (Correct); 27/04/2018 – PHILLIPS 66 EXPECTS FINAL INVESTMENT DECISION ON ETHANE CRACKER IN LATE 2019 -CEO; 10/04/2018 – Phillips 66 Alliance refinery raises production on reformer, HTUs; 27/04/2018 – PHILLIPS 66 QTRLY TOTAL REVENUES AND OTHER INCOME $24,046 MLN VS $23,712 MLN; 27/04/2018 – PHILLIPS 66 BEGINS 1Q EARNINGS CONFERENCE CALL; 17/04/2018 – Phillips 66 Reports Equipment Issues at Sweeny Refinery in Texas; 09/04/2018 – PHILLIPS 66 JV BORGER TEXAS REFINERY CONTINUING TO RESTART UNITS AFTER OVERHAUL; 27/04/2018 – PHILLIPS 66 CONCLUDES 1Q EARNINGS CONFERENCE CALL

Westend Advisors Llc decreased its stake in Biogen Inc. (BIIB) by 15.26% based on its latest 2018Q3 regulatory filing with the SEC. Westend Advisors Llc sold 18,868 shares as the company’s stock declined 6.12% with the market. The institutional investor held 104,745 shares of the biological products (no diagnostic substances) company at the end of 2018Q3, valued at $37.01B, down from 123,613 at the end of the previous reported quarter. Westend Advisors Llc who had been investing in Biogen Inc. for a number of months, seems to be less bullish one the $66.51 billion market cap company. The stock increased 1.06% or $3.47 during the last trading session, reaching $330.1. About 462,009 shares traded. Biogen Inc. (NASDAQ:BIIB) has declined 0.04% since January 10, 2018 and is downtrending. It has underperformed by 0.04% the S&P500. Some Historical BIIB News: 20/04/2018 – $BIIB $IONS Interesting slide on antisense and gene therapy being “Complementary”, “Combination / sequential”. Will see if Biogen answer any question re $AVXS; 10/04/2018 – AveXis sells on Novartis approach; 12/03/2018 – Biogen To Buy Schizophrenia Treatment From Pfizer For Up To $590 Million — MarketWatch; 20/04/2018 – BIOGEN – CO, IONIS EXPANDED COLLABORATION THROUGH NEW 10-YR AGREEMENT TO DEVELOP NOVEL ANTISENSE DRUG CANDIDATES FOR RANGE OF NEUROLOGICAL DISEASES; 20/04/2018 – Biogen to pay $1 billion to Ionis in new partnership; 24/04/2018 – BIOGEN INC – QTRLY TYSABRI REVENUE OF $$462 MLN VS. $545 MLN REPORTED LAST YEAR; 24/04/2018 – BIOGEN 1Q REV. $3.1B, EST. $3.15B; 07/05/2018 – Biogen Celebrates 40 Years as a Pioneer in Neuroscience; 05/04/2018 – Biogen, Samsung Bioepis in Settlement With AbbVie on Humira Biosimilar in Europe; 12/03/2018 – BIOGEN: SPINRAZA TRIAL SHOWED IMPROVED MOTOR FUNCTION

Among 35 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 27 have Buy rating, 0 Sell and 8 Hold. Therefore 77% are positive. Biogen Idec Inc. had 147 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Buy” rating by Guggenheim on Tuesday, April 24. On Tuesday, April 24 the stock rating was maintained by Stifel Nicolaus with “Buy”. The stock has “Market Perform” rating by Bernstein on Friday, October 19. As per Tuesday, June 7, the company rating was downgraded by Citigroup. The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Monday, November 27 by BMO Capital Markets. The company was maintained on Sunday, February 4 by Mizuho. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Neutral” rating by Robert W. Baird on Tuesday, July 10. The firm earned “Hold” rating on Wednesday, June 14 by Morgan Stanley. UBS maintained Biogen Inc. (NASDAQ:BIIB) rating on Wednesday, October 25. UBS has “Neutral” rating and $318 target. The firm has “Outperform” rating given on Monday, November 7 by Leerink Swann.

Analysts await Biogen Inc. (NASDAQ:BIIB) to report earnings on January, 29 before the open. They expect $6.72 EPS, up 27.76% or $1.46 from last year’s $5.26 per share. BIIB’s profit will be $1.35B for 12.28 P/E if the $6.72 EPS becomes a reality. After $7.40 actual EPS reported by Biogen Inc. for the previous quarter, Wall Street now forecasts -9.19% negative EPS growth.

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Seekingalpha.com which released: “FDA to “take action” against branded drug makers using scare tactics to thwart biosimilar competition – Seeking Alpha” on January 10, 2019, also Nasdaq.com with their article: “Biogen Inks Two Deals to Make Drugs for Neurological Diseases – Nasdaq” published on January 07, 2019, Seekingalpha.com published: “Biogen down 5%, sell-siders soften outlook – Seeking Alpha” on December 18, 2018. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Streetinsider.com and their article: “Biogen (BIIB) PT Lowered to $372 at Oppenheimer – StreetInsider.com” published on December 18, 2018 as well as Seekingalpha.com‘s news article titled: “EMA grants Prime status for Roche’s risdiplam for SMA – Seeking Alpha” with publication date: December 17, 2018.

Westend Advisors Llc, which manages about $1045.24B US Long portfolio, upped its stake in Ishares 0 (STIP) by 6,444 shares to 61,806 shares, valued at $6.11 billion in 2018Q3, according to the filing. It also increased its holding in Spdr Gold Trust Etf (GLD) by 9 shares in the quarter, for a total of 123 shares, and has risen its stake in Ishares Floating Rate Bond Etf (FLOT).

Since September 26, 2018, it had 0 insider purchases, and 1 sale for $350,000 activity.

Investors sentiment decreased to 1.01 in Q3 2018. Its down 0.01, from 1.02 in 2018Q2. It is negative, as 45 investors sold BIIB shares while 334 reduced holdings. 138 funds opened positions while 243 raised stakes. 167.21 million shares or 1.69% less from 170.10 million shares in 2018Q2 were reported. Sei Investments Company invested in 0.16% or 128,282 shares. Thompson Siegel And Walmsley Ltd Company accumulated 396 shares. Parallax Volatility Advisers LP reported 9,200 shares. First American Comml Bank reported 0.16% in Biogen Inc. (NASDAQ:BIIB). Profund Ltd Company reported 84,515 shares. Canandaigua National Bank & Trust And Trust reported 802 shares or 0.05% of all its holdings. Next Financial owns 377 shares. Cetera Advsr Limited Liability Corp owns 1,904 shares. Acadian Asset Mngmt Limited Liability owns 122,418 shares. Arvest Bankshares Division has invested 1.01% in Biogen Inc. (NASDAQ:BIIB). Optimum Invest Advsr reported 0.1% stake. Reliance Trust Of Delaware holds 0.71% or 12,950 shares. Fiduciary Trust has 4,161 shares for 0.04% of their portfolio. Rampart Management Llc, a Massachusetts-based fund reported 4,225 shares. Virginia Retirement Et Al reported 46,500 shares.

Among 22 analysts covering Phillips 66 (NYSE:PSX), 13 have Buy rating, 0 Sell and 9 Hold. Therefore 59% are positive. Phillips 66 had 96 analyst reports since August 4, 2015 according to SRatingsIntel. JP Morgan maintained Phillips 66 (NYSE:PSX) rating on Monday, June 4. JP Morgan has “Neutral” rating and $132 target. The firm has “Hold” rating given on Thursday, June 1 by Jefferies. Cowen & Co initiated Phillips 66 (NYSE:PSX) on Monday, March 28 with “Market Perform” rating. The firm has “Overweight” rating by JP Morgan given on Tuesday, October 30. The company was maintained on Monday, December 31 by Raymond James. The stock of Phillips 66 (NYSE:PSX) has “Neutral” rating given on Monday, November 2 by JP Morgan. Jefferies maintained the shares of PSX in report on Tuesday, April 24 with “Sell” rating. The stock of Phillips 66 (NYSE:PSX) earned “Buy” rating by Scotia Capital on Wednesday, January 10. The rating was maintained by Piper Jaffray on Wednesday, August 2 with “Buy”. Piper Jaffray maintained the shares of PSX in report on Monday, November 13 with “Buy” rating.

Since November 20, 2018, it had 1 buy, and 0 sales for $1.98 million activity.

More important recent Phillips 66 (NYSE:PSX) news were published by: Seekingalpha.com which released: “Phillips 66: Buffett Dividend Stock On Sale – Seeking Alpha” on December 06, 2018, also Investorplace.com published article titled: “5 Oil Stocks to Buy Even If Oil Prices Keep Falling – Investorplace.com”, Seekingalpha.com published: “Phillips 66 – My Opinion After The Third Quarter 2018 – Seeking Alpha” on December 14, 2018. More interesting news about Phillips 66 (NYSE:PSX) was released by: Seekingalpha.com and their article: “Phillips 66: Reloading The Growth Pipeline In 2019 – Seeking Alpha” with publication date: December 16, 2018.

Investors sentiment increased to 1.19 in Q3 2018. Its up 0.03, from 1.16 in 2018Q2. It improved, as 35 investors sold PSX shares while 356 reduced holdings. 113 funds opened positions while 351 raised stakes. 305.42 million shares or 2.74% less from 314.02 million shares in 2018Q2 were reported. Pitcairn Comm stated it has 0.07% of its portfolio in Phillips 66 (NYSE:PSX). Corecommodity Management Limited Liability Corporation holds 11,568 shares or 0.65% of its portfolio. Bluecrest Capital invested in 0.02% or 7,155 shares. Howe & Rusling reported 1,147 shares stake. Utah Retirement invested in 78,198 shares. Westwood Grp Inc Inc owns 9,282 shares or 0.01% of their US portfolio. Csat Advisory LP owns 35 shares or 0% of their US portfolio. Weik Capital Mgmt reported 0.69% stake. Bailard reported 0.01% in Phillips 66 (NYSE:PSX). Buckingham Asset Mgmt reported 4,937 shares. Aristotle Ltd Com holds 2.58% in Phillips 66 (NYSE:PSX) or 3.64 million shares. Pittenger And Anderson owns 0.46% invested in Phillips 66 (NYSE:PSX) for 51,924 shares. Blume Mngmt reported 175 shares. Ameritas Invest Prns Incorporated owns 21,337 shares or 0.11% of their US portfolio. Miracle Mile Advsrs Ltd Liability Company owns 0.32% invested in Phillips 66 (NYSE:PSX) for 31,627 shares.

Phillips 66 (NYSE:PSX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.